Top

Journal of Endocrinological Investigation

Published in:

01-01-2022 | COVID-19 | Original Article

Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis

Authors: R. Pal, M. Banerjee, S. K. Bhadada, A. J. Shetty, B. Singh, A. Vyas

Published in: Journal of Endocrinological Investigation | Issue 1/2022

Abstract

Purpose

To provide a precise summary and collate the hitherto available clinical evidence on the effect of vitamin D supplementation on clinical outcomes in COVID-19 patients.

Methods

PubMed/MEDLINE, Scopus, and Web of Science databases were systematically searched using appropriate keywords till June 8, 2021, to identify observational studies and randomized controlled trials (RCTs) reporting adverse clinical outcomes (ICU admission and/or mortality) in COVID-19 patients receiving vitamin D supplementation vs. those not receiving the same. Both prior use and use of vitamin D after COVID-19 diagnosis were considered. Unadjusted/adjusted pooled odds ratio (OR) with 95% confidence intervals (CI) were calculated (PROSPERO registration number CRD42021248488).

Results

We identified 13 studies (10 observational, 3 RCTs) pooling data retrieved from 2933 COVID-19 patients. Pooled analysis of unadjusted data showed that vitamin D use in COVID-19 was significantly associated with reduced ICU admission/mortality (OR 0.41, 95% CI: 0.20, 0.81, p = 0.01, I² = 66%, random-effects model). Similarly, on pooling adjusted risk estimates, vitamin D was also found to reduce the risk of adverse outcomes (pooled OR 0.27, 95% CI: 0.08, 0.91, p = 0.03, I² = 80%, random-effects model). Subgroup analysis showed that vitamin D supplementation was associated with improved clinical outcomes only in patients receiving the drug post-COVID-19 diagnosis and not in those who had received vitamin D before diagnosis.

Conclusions

Vitamin D supplementation might be associated with improved clinical outcomes, especially when administered after the diagnosis of COVID-19. However, issues regarding the appropriate dose, duration, and mode of administration of vitamin D remain unanswered and need further research.

Available only for authorised users

Meltzer DO, Best TJ, Zhang H et al (2020) Association of vitamin D status and other clinical characteristics with COVID-19 test results. JAMA Netw Open 3:e2019722. https://doi.org/10.1001/jamanetworkopen.2020.19722CrossRefPubMedPubMedCentral

Pal R, Ram S, Zohmangaihi D et al (2020) High prevalence of hypocalcemia in non-severe COVID-19 patients: a retrospective case-control study. Front Med 7:590805. https://doi.org/10.3389/fmed.2020.590805CrossRef

Munshi R, Hussein MH, Toraih EA et al (2021) Vitamin D insufficiency as a potential culprit in critical COVID-19 patients. J Med Virol 93:733–740. https://doi.org/10.1002/jmv.26360CrossRefPubMed

Mariani J, Giménez VMM, Bergam I et al (2020) Association between vitamin D deficiency and COVID-19 incidence, complications, and mortality in 46 countries: an ecological study. Health Secur. https://doi.org/10.1089/hs.2020.0137CrossRefPubMed

Radujkovic A, Hippchen T, Tiwari-Heckler S et al (2020) Vitamin D deficiency and outcome of COVID-19 patients. Nutrients. https://doi.org/10.3390/nu12092757CrossRefPubMedPubMedCentral

Baktash V, Hosack T, Patel N et al (2020) Vitamin D status and outcomes for hospitalised older patients with COVID-19. Postgrad Med J. https://doi.org/10.1136/postgradmedj-2020-138712CrossRefPubMed

Annweiler G, Corvaisier M, Gautier J et al (2020) Vitamin D supplementation associated to better survival in hospitalized frail elderly COVID-19 patients: the GERIA-COVID quasi-experimental study. Nutrients 12:3377. https://doi.org/10.3390/nu12113377CrossRefPubMedCentral

Annweiler C, Hanotte B, Grandin de l’Eprevier C et al (2020) Vitamin D and survival in COVID-19 patients: a quasi-experimental study. J Steroid Biochem Mol Biol 204:105771. https://doi.org/10.1016/j.jsbmb.2020.105771CrossRefPubMedPubMedCentral

Ling SF, Broad E, Murphy R et al (2020) High-dose cholecalciferol booster therapy is associated with a reduced risk of mortality in patients with COVID-19: a cross-sectional multi-centre observational study. Nutrients 12:3799. https://doi.org/10.3390/nu12123799CrossRefPubMedCentral

10.

Giannini S, Passeri G, Tripepi G et al (2021) Effectiveness of in-hospital cholecalciferol use on clinical outcomes in comorbid COVID-19 patients: a hypothesis-generating study. Nutrients 13:219. https://doi.org/10.3390/nu13010219CrossRefPubMedPubMedCentral

11.

Entrenas Castillo M, Entrenas Costa LM, Vaquero Barrios JM et al (2020) Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: a pilot randomized clinical study. J Steroid Biochem Mol Biol 203:105751. https://doi.org/10.1016/j.jsbmb.2020.105751CrossRefPubMedPubMedCentral

12.

Hernández JL, Nan D, Fernandez-Ayala M et al (2020) Vitamin D status in hospitalized patients with SARS-CoV-2 infection. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgaa733CrossRef

13.

Jevalikar G, Mithal A, Singh A et al (2021) Lack of association of baseline 25-hydroxyvitamin D levels with disease severity and mortality in Indian patients hospitalized for COVID-19. Sci Rep 11:6258. https://doi.org/10.1038/s41598-021-85809-yCrossRefPubMedPubMedCentral

14.

Cereda E, Bogliolo L, Lobascio F et al (2021) Vitamin D supplementation and outcomes in coronavirus disease 2019 (COVID-19) patients from the outbreak area of Lombardy. Italy Nutrition 82:111055. https://doi.org/10.1016/j.nut.2020.111055CrossRefPubMed

15.

Murai IH, Fernandes AL, Sales LP et al (2021) Effect of a single high dose of vitamin D₃ on hospital length of stay in patients with moderate to severe COVID-19: a randomized clinical trial. JAMA 325:1053. https://doi.org/10.1001/jama.2020.26848CrossRefPubMed

16.

Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700–b2700. https://doi.org/10.1136/bmj.b2700CrossRefPubMedPubMedCentral

17.

Pal R, Bhadada SK (2021) Vitamin D supplementation and adverse clinical outcomes in COVID-19: a systematic review and meta-analysis. PROSPERO 2021 CRD42021248488. https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=248488

18.

Wells G, Shea B, O’Connell D et al (2013) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp

19.

Luchini C, Stubbs B, Solmi M, Veronese N (2017) Assessing the quality of studies in meta-analyses: advantages and limitations of the Newcastle Ottawa Scale. World J Meta-Anal 5:80. https://doi.org/10.13105/wjma.v5.i4.80CrossRef

20.

Higgins J, Sterne J, Savovic J et al (2016) A revised tool for assessing risk of bias in randomized trials. Cochrane Database Syst Rev 10:29–31

21.

Higgins JPT (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560. https://doi.org/10.1136/bmj.327.7414.557CrossRefPubMedPubMedCentral

22.

Alcala-Diaz JF, Limia-Perez L, Gomez-Huelgas R et al (2021) Calcifediol treatment and hospital mortality due to COVID-19: a cohort study. Nutrients 13:1760. https://doi.org/10.3390/nu13061760CrossRefPubMedPubMedCentral

23.

Lohia P, Nguyen P, Patel N, Kapur S (2021) Exploring the link between vitamin D and clinical outcomes in COVID-19. Am J Physiol-Endocrinol Metab 320:E520–E526. https://doi.org/10.1152/ajpendo.00517.2020CrossRefPubMedPubMedCentral

24.

Cangiano B, Fatti LM, Danesi L et al (2020) Mortality in an Italian nursing home during COVID-19 pandemic: correlation with gender, age, ADL, vitamin D supplementation, and limitations of the diagnostic tests. Aging 12:24522–24534. https://doi.org/10.18632/aging.202307CrossRefPubMedPubMedCentral

25.

Lakkireddy M, Gadiga SG, Malathi RD et al (2021) Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease. Sci Rep 11:10641. https://doi.org/10.1038/s41598-021-90189-4CrossRefPubMedPubMedCentral

26.

Rastogi A, Bhansali A, Khare N et al (2020) Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study). Postgrad Med J postgrad. https://doi.org/10.1136/postgradmedj-2020-139065CrossRef

27.

Sánchez-Zuno GA, González-Estevez G, Matuz-Flores MG et al (2021) Vitamin D levels in COVID-19 outpatients from Western Mexico: clinical correlation and effect of its supplementation. J Clin Med 10:2378. https://doi.org/10.3390/jcm10112378CrossRefPubMedPubMedCentral

28.

Tan CW, Ho LP, Kalimuddin S et al (2020) Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19). Nutrition 79–80:111017. https://doi.org/10.1016/j.nut.2020.111017CrossRefPubMed

29.

Hernández JL, Nan D, Fernandez-Ayala M et al (2021) Vitamin D status in hospitalized patients with SARS-CoV-2 infection. J Clin Endocrinol Metab 106:e1343–e1353. https://doi.org/10.1210/clinem/dgaa733CrossRefPubMed

30.

Heaney RP (2014) Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev 72:48–54. https://doi.org/10.1111/nure.12090CrossRefPubMed

31.

Kaufman HW, Niles JK, Kroll MH et al (2020) SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS ONE 15:e0239252. https://doi.org/10.1371/journal.pone.0239252CrossRefPubMedPubMedCentral

32.

Shah Alam M, Czajkowsky DM, Aminul Islam Md, Ataur Rahman Md (2021) The role of vitamin D in reducing SARS-CoV-2 infection: an update. Int Immunopharmacol 97:107686. https://doi.org/10.1016/j.intimp.2021.107686CrossRefPubMedPubMedCentral

33.

Charoenngam N, Shirvani A, Reddy N et al (2021) Association of vitamin D status with hospital morbidity and mortality in adult hospitalized patients with COVID-19. Endocr Pract 27:271–278. https://doi.org/10.1016/j.eprac.2021.02.013CrossRefPubMedPubMedCentral

34.

Akbar MR, Wibowo A, Pranata R, Setiabudiawan B (2021) Low Serum 25-hydroxyvitamin D (Vitamin D) level is associated with susceptibility to COVID-19, severity, and mortality: a systematic review and meta-analysis. Front Nutr 8:660420. https://doi.org/10.3389/fnut.2021.660420CrossRefPubMedPubMedCentral

35.

Teshome A, Adane A, Girma B, Mekonnen ZA (2021) The impact of vitamin D level on COVID-19 infection: systematic review and meta-analysis. Front Public Health 9:624559. https://doi.org/10.3389/fpubh.2021.624559CrossRefPubMedPubMedCentral

36.

Pereira M, Dantas Damascena A, Galvão Azevedo LM et al (2020) Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis. Crit Rev Food Sci Nutr. https://doi.org/10.1080/10408398.2020.1841090CrossRefPubMed

37.

Bassatne A, Basbous M, Chakhtoura M et al (2021) The link between COVID-19 and VItamin D (VIVID): a systematic review and meta-analysis. Metabolism. https://doi.org/10.1016/j.metabol.2021.154753CrossRefPubMedPubMedCentral

38.

Mercola J, Grant WB, Wagner CL (2020) Evidence regarding vitamin D and Risk of COVID-19 and its severity. Nutrients 12:3361. https://doi.org/10.3390/nu12113361CrossRefPubMedCentral

39.

Grant WB, Lahore H, McDonnell SL et al (2020) Evidence that vitamin D Supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients 12:988. https://doi.org/10.3390/nu12040988CrossRefPubMedCentral

40.

Grant WB, Lahore H, Rockwell MS (2020) The benefits of vitamin D supplementation for athletes: better performance and reduced risk of COVID-19. Nutrients 12:3741. https://doi.org/10.3390/nu12123741CrossRefPubMedCentral

41.

Brice DC, Diamond G (2020) Antiviral activities of human host defense peptides. Curr Med Chem 27:1420–1443. https://doi.org/10.2174/0929867326666190805151654CrossRefPubMed

42.

Raucci F, Mansour AA, Casillo GM et al (2020) Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms. Autoimmun Rev 19:102572. https://doi.org/10.1016/j.autrev.2020.102572CrossRefPubMedPubMedCentral

43.

Pacha O, Sallman MA, Evans SE (2020) COVID-19: a case for inhibiting IL-17? Nat Rev Immunol 20:345–346. https://doi.org/10.1038/s41577-020-0328-zCrossRefPubMedPubMedCentral

44.

Bilezikian JP, Bikle D, Hewison M et al (2020) Mechanisms in endocrinology: vitamin D and COVID-19. Eur J Endocrinol 183:R133–R147. https://doi.org/10.1530/EJE-20-0665CrossRefPubMed

45.

Zou Z, Yan Y, Shu Y et al (2014) Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections. Nat Commun. https://doi.org/10.1038/ncomms4594CrossRefPubMed

46.

Pal R, Bhansali A (2020) COVID-19, diabetes mellitus and ACE2: the conundrum. Diabetes Res Clin Pract 162:108132. https://doi.org/10.1016/j.diabres.2020.108132CrossRefPubMedPubMedCentral

47.

Malek Mahdavi A (2020) A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: implications for a potential treatment for COVID-19. Rev Med Virol. https://doi.org/10.1002/rmv.2119CrossRefPubMedPubMedCentral

48.

Shah K, Saxena D, Mavalankar D (2021) Vitamin D supplementation, COVID-19 and disease severity: a meta-analysis. QJM Int J Med. https://doi.org/10.1093/qjmed/hcab009CrossRef

49.

Annweiler C, Mercat A, Souberbielle J-C (2021) Learning from previous methodological pitfalls to propose well-designed trials on vitamin D in COVID-19. J Steroid Biochem Mol Biol 211:105901. https://doi.org/10.1016/j.jsbmb.2021.105901CrossRefPubMedPubMedCentral

50.

Maghbooli Z, Sahraian MA, Ebrahimi M et al (2020) Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection. PLoS ONE 15:e0239799. https://doi.org/10.1371/journal.pone.0239799CrossRefPubMedPubMedCentral

51.

Kearns MD, Binongo JNG, Watson D et al (2015) The effect of a single, large bolus of vitamin D in healthy adults over the winter and following year: a randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr 69:193–197. https://doi.org/10.1038/ejcn.2014.209CrossRefPubMed

52.

Barker T, May HT, Doty JR et al (2021) Vitamin D supplementation protects against reductions in plasma 25-hydroxyvitamin D induced by open-heart surgery: Assess-d trial. Physiol Rep. https://doi.org/10.14814/phy2.14747CrossRefPubMedPubMedCentral

53.

Griffin G, Hewison M, Hopkin J et al (2021) Perspective: Vitamin D supplementation prevents rickets and acute respiratory infections when given as daily maintenance but not as intermittent bolus: implications for COVID-19. Clin Med 21:e144–e149. https://doi.org/10.7861/clinmed.2021-0035CrossRef

54.

Ketha H, Thacher TD, Oberhelman SS et al (2018) Comparison of the effect of daily versus bolus dose maternal vitamin D3 supplementation on the 24,25-dihydroxyvitamin D3 to 25-hydroxyvitamin D3 ratio. Bone 110:321–325. https://doi.org/10.1016/j.bone.2018.02.024CrossRefPubMedPubMedCentral

Title: Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis
Authors: R. Pal
M. Banerjee
S. K. Bhadada
A. J. Shetty
B. Singh
A. Vyas
Publication date: 01-01-2022
Publisher: Springer International Publishing
Keyword: COVID-19
Published in: Journal of Endocrinological Investigation / Issue 1/2022
Electronic ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-021-01614-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

The single-point insulin sensitivity estimator (SPISE) index is a strong predictor of abnormal glucose metabolism in overweight/obese children: a long-term follow-up study

Non-thyroidal illness syndrome and SARS-CoV-2-associated multisystem inflammatory syndrome in children

Letter to the editor Re: Faienza MF, Brunetti G, Grugni G, et al. The genetic background and vitamin D supplementation can affect irisin levels in Prader–Willi syndrome. J Endocrinol Invest 2021 Mar 3. https://doi.org/10.1007/s40618-021-01533-4

Thyroid surgery during the COVID-19 pandemic: results from a systematic review

In Memoriam: Michele Muggeo 1938–2021

Effects of first-line diabetes therapy with biguanides, sulphonylurea and thiazolidinediones on the differentiation, proliferation and apoptosis of islet cell populations

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials